With the new EU drug strategy now adopted, key questions remain about its direction and implementation—especially the balance between public health, human rights, and security. We spoke with Anna Dovbakh, Chair of the Civil Society Forum on Drugs, about what the strategy means in practice and the role of civil society moving forward.
Chapters:
00:39 EU Drug Strategy Explained 01:54 Real Impact on Member States? 02:44 Civil Society’s Assessment 05:26 Shift Toward Security? 09:24 Cannabis Reform in the EU 11:48 Eastern Europe & Security Focus 15:41 Role of Civil Society 19:35 Military vs Social Spending 22:33 What Should the EU Do Next?
Podden och tillhörande omslagsbild på den här sidan tillhör
Rights Reporter Foundation. Innehållet i podden är skapat av Rights Reporter Foundation och inte av,
eller tillsammans med, Poddtoppen.